Abstract
Background
Determining the cause of refractory seizures and/or interictal continuum (IIC) findings in the critically ill patient remains a challenge. These electrographic abnormalities may represent primary ictal pathology or may instead be driven by an underlying infectious, inflammatory, or neoplastic pathology that requires targeted therapy. In these cases, it is unclear whether escalating antiepileptic therapy will be helpful or harmful. Herein, we report the use of serial [F-18] fluorodeoxyglucose positron emission tomography (FDG-PET) coupled with induced electrographic burst suppression to distinguish between primary and secondary ictal pathologies. We propose that anesthetic suppression of hypermetabolic foci suggests clinical responsiveness to escalating antiepileptic therapy, whereas non-suppressible hypermetabolic foci are suggestive of non-ictal pathologies that likely require multimodal therapy.
Methods
We describe 6 patients who presented with electrographic findings of seizure or IIC abnormalities, severe neurologic injury, and clinical concern for confounding pathologies. All patients were continuously monitored on video electroencephalography (cvEEG). Five patients underwent at least two sequential FDG-PET scans of the brain: one in a baseline state and the second while under electrographic burst suppression. FDG-avid loci and EEG tracings were compared pre- and post-burst suppression. One patient underwent a single FDG-PET scan while burst-suppressed.
Results
Four patients had initially FDG-avid foci that subsequently resolved with burst suppression. Escalation of antiepileptic therapy in these patients resulted in clinical improvement, suggesting that the foci were related to primary ictal pathology. These included clinical diagnoses of electroclinical status epilepticus, new-onset refractory status epilepticus, stroke-like migraine attacks after radiotherapy, and epilepsy secondary to inflammatory cerebral amyloid angiopathy. Conversely, two patients with high-grade EEG abnormalities had FDG-avid foci that persisted despite burst suppression. The first presented with a poor examination, fever, and concern for encephalitis. Postmortem pathology confirmed suspicion of herpes simplex virus encephalitis. The second patient presented with concern for checkpoint inhibitor-induced autoimmune encephalitis. The persistence of the FDG-avid focus, despite electrographic burst suppression, guided successful treatment through escalation of immunosuppressive therapy.
Conclusions
In appropriately selected patients, FDG-PET scans while in burst suppression may help dissect the underlying pathophysiologic cause of IIC findings observed on EEG and guide tailored therapy.
Similar content being viewed by others
Change history
06 May 2020
In the original article, Figure 5 has incorrect EEG images and the corrected version is shown below.
References
Sivaraju A, Gilmore EJ. Understanding and managing the ictal-interictal continuum in neurocritical care. Curr Treat Options Neurol. 2016;18:8.
Johnson EL, Kaplan PW. Population of the ictal-interictal zone: the significance of periodic and rhythmic activity. Clin Neurophysiol Pract. 2017;2:107–18.
de Bruijn MAAM, van Sonderen A, van Coevorden-Hameete MH, et al. Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABA. Neurology. 2019;92:e2185–e96.
Waziri A, Claassen J, Stuart RM, et al. Intracortical electroencephalography in acute brain injury. Ann Neurol. 2009;66:366–77.
Claassen J, Perotte A, Albers D, et al. Nonconvulsive seizures after subarachnoid hemorrhage: multimodal detection and outcomes. Ann Neurol. 2013;74:53–64.
Kim JA, Rosenthal ES, Biswal S, et al. Epileptiform abnormalities predict delayed cerebral ischemia in subarachnoid hemorrhage. Clin Neurophysiol. 2017;128:1091–9.
Raichle ME, Gusnard DA. Appraising the brain's energy budget. Proc Natl Acad Sci USA. 2002;99:10237–9.
Engel J, Kuhl DE, Phelps ME. Patterns of human local cerebral glucose metabolism during epileptic seizures. Science. 1982;218:64–6.
Siclari F, Prior JO, Rossetti AO. Ictal cerebral positron emission tomography (PET) in focal status epilepticus. Epilepsy Res. 2013;105:356–61.
Schur S, Allen V, White A, et al. Significance of FDG-PET hypermetabolism in children with intractable focal epilepsy. Pediatr Neurosurg. 2018;53:153–62.
Hajek M, Antonini A, Leenders KL, Wieser HG. Epilepsia partialis continua studied by PET. Epilepsy Res. 1991;9:44–8.
Sarikaya I. PET studies in epilepsy. Am J Nucl Med Mol Imaging. 2015;5:416–30.
Franck G, Sadzot B, Salmon E, et al. Study of cerebral metabolism and blood flow in partial complex epilepsy and status epilepticus in man using positron emission tomography. Rev Electroencephalogr Neurophysiol Clin. 1986;16:199–21616.
Subramaniam T, Jain A, Hall LT, et al. Lateralized periodic discharges frequency correlates with glucose metabolism. Neurology. 2019;92:e670–e4.
Struck AF, Westover MB, Hall LT, Deck GM, Cole AJ, Rosenthal ES. Metabolic correlates of the ictal-interictal continuum: FDG-PET during continuous EEG. Neurocrit Care. 2016;24:324–31.
Kampe KK, Rotermund R, Tienken M, et al. Diagnostic value of positron emission tomography combined with computed tomography for evaluating critically ill neurological patients. Front Neurol. 2017;8:33.
Morbelli S, Djekidel M, Hesse S, et al. Role of (18)F-FDG-PET imaging in the diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:1009–10.
Probasco JC, Solnes L, Nalluri A, et al. Abnormal brain metabolism on FDG-PET/CT is a common early finding in autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm. 2017;4:e352.
Trevino-Peinado C, Arbizu J, Irimia P, Riverol M, Martínez-Vila E. Monitoring the effect of immunotherapy in autoimmune limbic encephalitis using 18F-FDG PET. Clin Nucl Med. 2015;40:e441–3.
Singhal T, Solomon I, Akbik F, Smirnakis S, Vaitkevicius H. Ventral striatal and septal area hypermetabolism on FDG-PET in herpes simplex viral encephalitis. J Neurovirol. 2019;21:118–20.
Kaisti KK, Metsahonkala L, Teras M, et al. Effects of surgical levels of propofol and sevoflurane anesthesia on cerebral blood flow in healthy subjects studied with positron emission tomography. Anesthesiology. 2002;96:1358–70.
Jeong YB, Kim JS, Jeong SM, Park JW, Choi IC. Comparison of the effects of sevoflurane and propofol anaesthesia on regional cerebral glucose metabolism in humans using positron emission tomography. J Int Med Res. 2006;34:374–84.
Author information
Authors and Affiliations
Contributions
HV designed the study. FA and HV wrote the manuscript with critical review from AD, MR, TS, and JL. MR provided qualitative and quantitative PET imaging data. All authors were involved in clinical care of the patients and interpretation of the supporting data.
Corresponding author
Ethics declarations
Source of Support
None.
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical Approval
Our project has adhered to ethical guidelines and standards at Brigham and Women’s Hospital.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Akbik, F., Robertson, M., Das, A.S. et al. The PET Sandwich: Using Serial FDG-PET Scans with Interval Burst Suppression to Assess Ictal Components of Disease. Neurocrit Care 33, 657–669 (2020). https://doi.org/10.1007/s12028-020-00956-w
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-020-00956-w